Is Sarepta Therapeutics Inc (NASDAQ: SRPT) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

SRPT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Sarepta Therapeutics Inc is $12.42B. A total of 0.51 million shares were traded on the day, compared to an average of 935.08K shares.

In the most recent transaction, Estepan Ian Michael sold 5,985 shares of SRPT for 137.36 per share on Aug 30 ’24. After the transaction, the Chief Financial Officer now owns 33,946 company shares. In a previous transaction on Aug 30 ’24, Estepan Ian Michael bought 5,985 shares at 137.37 per share.

Among the insiders who bought shares, Chambers Michael Andrew acquired of 37,038 shares on Aug 16 ’24 at a per-share price of $133.80. This resulted in the Director holding 284,034 shares of SRPT after the transaction. In another insider transaction, Brown Ryan Edward sold 38,957 shares at $161.61 per share on Jun 25 ’24. Company shares held by the EVP, General Counsel now total 17,129.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SRPT has a high of $173.25 and a low of $55.25.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $11.30, while its Total Shareholder’s Equity was $928.01M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 4.67.

Most Popular

Related Posts